Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
30 Junho 2009 - 11:22AM
PR Newswire (US)
LAKE FOREST, Ill., June 30 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE: HSP), a global specialty pharmaceutical and medication
delivery company, today announced agreements with MedAssets on
intravenous (I.V.) solutions and gravity I.V. equipment, and a
renewal of its agreement for infusion devices. The five-year
MedAssets agreements are effective as of June 1, 2009, for I.V.
solutions and equipment, and July 1, 2009, for infusion devices.
These new agreements represent a first for Hospira from a contract
award position on I.V. solutions and gravity I.V. equipment.
"MedAssets shares Hospira's commitment to improving patient and
healthcare safety, as well as finding ways to reduce the high costs
of healthcare," said Pete Baker, vice president and general
manager, Commercial Service Operations, Hospira. "We look forward
to continuing our work with MedAssets' member healthcare
institutions to drive these goals." The agreements, all of which
run through June 30, 2014, are multi-source awards. They include
Hospira's general-purpose medication management technologies, such
as the Plum A+(R) device; the next-generation Symbiq(R) infusion
system with Hospira MedNet(R) safety software; and pain management
pumps, such as the LifeCare PCA(R) device with Hospira MedNet(R)
safety software, and GemStar(R) ambulatory devices. These products
play a critical role in improving patient safety as well as
enhancing quality of care and clinician workflow. Also covered
within the agreements is access to contracts for Hospira's I.V.
solutions, including the company's environmentally preferable
VisIV(R) container, and the IV solutions' associated equipment
portfolio. "We are pleased to expand our relationship with
Hospira," said Mark Miriani, president of MedAssets Supply Chain
Systems. "Adding Hospira's full line of I.V. solutions and gravity
I.V. equipment to our existing portfolio provides additional
options for our members as part of our flexible, customer-driven
approach to reducing supply expenses for our members." About
MedAssets MedAssets (NASDAQ:MDAS) partners with healthcare
providers to improve their financial strength by implementing spend
management and revenue cycle solutions that help control cost,
improve margins and cash flow, increase regulatory compliance, and
optimize operational efficiency. MedAssets serves more than 125
health systems, 3,300 hospitals and 30,000 non-acute care
healthcare providers. For more information, visit
http://www.medassets.com/. About Hospira Hospira, Inc. is a global
specialty pharmaceutical and medication delivery company dedicated
to Advancing Wellness(TM). As the world leader in specialty generic
injectable pharmaceuticals, Hospira offers one of the broadest
portfolios of generic acute-care and oncology injectables, as well
as integrated infusion therapy and medication management solutions.
Through its products, Hospira helps improve the safety, cost and
productivity of patient care. The company is headquartered in Lake
Forest, Ill., and has more than 14,000 employees. Learn more at
http://www.hospira.com/.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Daniel Rosenberg, +1-224-212-3366, or Financial Community,
Karen King, +1-224-212-2711, both of Hospira, Inc. Web Site:
http://www.hospira.com/
Copyright